Active Ingredient History

NOW
  • Now
Relugolix, sold under the brand names Orgovyx and Relumina among others, is a gonadotropin-releasing hormone antagonist medication which is used in the treatment of prostate cancer in men and uterine fibroids in women. It is taken by mouth.   Wikipedia

  • SMILES: CONC(=O)Nc1ccc(cc1)c2sc3N(Cc4c(F)cccc4F)C(=O)N(C(=O)c3c2CN(C)C)c5ccc(OC)nn5
  • InChIKey: AOMXMOCNKJTRQP-UHFFFAOYSA-N
  • Mol. Mass: 623.64
  • ALogP: 3.75
  • ChEMBL Molecule:
More Chemistry

Drug Pricing (per unit)

More Pricing Detail

Note: This drug pricing data is preliminary, incomplete, and may contain errors.

Combination drugs

( relugolix (ORGOVYX), estradiol (progynon depot), norethindrone - other name: relugolix/e2/neta fdc )
1-(4-(1-(2,6-difluorobenzyl)-5-((dimethylamino)methyl)-3-(6-methoxypyridazin-3-yl)-2,4-dioxo-1,2,3,4-tetrahydrothieno(2,3-d)pyrimidin-6-yl)phenyl)-3-methoxyurea | relugolix | tak385 | tak 385 | tak-385

Feedback

Data collection and curation is an ongoing process for CDEK - if you notice any information here to be missing or incorrect, please let us know! When possible, please include a source URL (we verify all data prior to inclusion).

Report issue